Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Dec 21:3:170.
doi: 10.3389/fendo.2012.00170. eCollection 2012.

Inflammation in the pathogenesis of microvascular complications in diabetes

Affiliations

Inflammation in the pathogenesis of microvascular complications in diabetes

Dung V Nguyen et al. Front Endocrinol (Lausanne). .

Abstract

Diabetes and hyperglycemia create a proinflammatory microenvironment that progresses to microvascular complications such as nephropathy, retinopathy, and neuropathy. Diet-induced insulin resistance is a potential initiator of this change in type 2 diabetes which can increase adipokines and generate a chronic low-grade inflammatory state. Advanced glycation end-products and its receptor, glycation end-products AGE receptor axis, reactive oxygen species, and hypoxia can also interact to worsen complications. Numerous efforts have gained way to understanding the mechanisms of these modulators and attenuation of the inflammatory response, however, effective treatments have still not emerged. The complexity of inflammatory signaling may suggest a need for multi-targeted therapy. This review presents recent findings aimed at new treatment strategies.

Keywords: advanced glycation end-products; diabetes mellitus; inflammation; inflammatory cytokines; microvascular complications; oxidative stress.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
General pathway in the progression of diabetic microvascular complications.
FIGURE 2
FIGURE 2
Activation of RAS can lead to progressive or protective effects depending on the signaling mechanisms.

References

    1. Abdelsamie S. A., Li Y., Huang Y., Lee M. H., Klein R. L., Virella G., et al. (2011). Oxidized LDL immune complexes stimulate collagen IV production in mesangial cells via Fc gamma receptors I and III. Clin. Immunol. 139 258–266 - PMC - PubMed
    1. Alfieri A., Watson J. J., Kammerer R. A., Tasab M., Progias P., Reeves K., et al. (2012). Angiopoietin-1 variant reduces LPS-induced microvascular dysfunction in a murine model of sepsis. Crit. Care 16 R182 - PMC - PubMed
    1. Alkhalaf A., Kleefstra N., Groenier K. H., Bilo H. J. G., Gans R. O. B., Heeringa P., et al. (2012). Effect of benfotiamine on advanced glycation endproducts and markers of endothelial dysfunction and inflammation in diabetic nephropathy. PLoS ONE 7:e40427 10.1371/journal.pone.0040427 - DOI - PMC - PubMed
    1. Asano T., Wakisaka M., Yoshinari M., Iino K., Sonoki K., Iwase M., et al. (2000). Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation. Biochim. Biophys. Acta 1497 148–154 - PubMed
    1. Babaei-Jadidi R., Karachalias N., Ahmed N., Battah S., Thornalley P. J. (2003). Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 52 2110–2120 - PubMed

LinkOut - more resources